Pinderfields nurse becomes world's first volunteer for new Covid-19 treatment trials
and on Freeview 262 or Freely 565
Karen Simeson, who is from Ossett and works at ICU, was the first to receive the treatment that uses man-made proteins that act like natural human antibodies in the immune system.
Advertisement
Hide AdAdvertisement
Hide AdUp to 5,000 patients globally will be used to trial the effectiveness of biopharmaceutical company AstraZeneca's "antibody cocktail", 1,000 of them in Britain.
The UK Government has an in principle agreement which secures access to one million doses of the long-acting antibodies if they are successful in the trials
The treatment mimics natural antibodies and has the potential to treat and prevent disease progression in patients already infected with the virus, as well as to be given as a preventative intervention prior to exposure to the virus, AstraZeneca has said.
Advertisement
Hide AdAdvertisement
Hide AdSir Mene Pangalos, executive vice president of biopharmaceuticals R&D at AstraZeneca, said the treatment can be injected or administered intravenously.
He added: “Today is an exciting milestone in the development of our long-acting combination which has the potential to provide immediate and long-lasting effect in both preventing and treating Covid-19 infections.
"There is going to be a significant number of people - even in a world where vaccines are highly effective - who will not respond to vaccines, or in fact will not take vaccines."
Advertisement
Hide AdAdvertisement
Hide AdProf Andrew Ustianowski, of the National Institute of Health Research (NIHR), and chief investigator of the study said: "This is a really exciting development in the fight against Covid-19, which takes a very different approach to other studies involving vaccines.
"Vaccines work mainly by inducing a person's immune system to produce antibodies that inhibit or neutralise the virus, but some people don't respond well to vaccines, or cannot be given them.
"What we are investigating in this study is whether we can provide protection by giving antibodies, that have been shown to neutralise the virus, by injection into the muscle.
Advertisement
Hide AdAdvertisement
Hide Ad"The hope is that this will then provide good protection for many months against infection."
People can still volunteer to take part in the trials, they must be 18 or over, must not have a previously-confirmed diagnosis of Covid-19 and must have an increased risk of vulnerability, such as being front line healthcare worker.
Sign up now by clicking here or by calling 07540 305088. This is a messaging service, so leave a message with your contact details (including name and phone number) and one of the team will call you back.